Author: Amy Lambright Murphy

Experts from the University of Wisconsin School of Medicine and Public Health recently shared insight and answered audience questions about aducanumab (marketed as Aduhelm) via a Facebook Live presentation. Learn how this new treatment for Alzheimer’s disease targets amyloid protein buildup, possible side effects of...

Thanks to your generous contributions during the American Family Insurance Championship #MatchingChallenge, you helped raise $78,168 for the UW Initiative to End Alzheimer’s! Your support will directly fund treatment and prevention strategies, help people recognize symptoms, improve care and benefit researchers at University of Wisconsin–Madison...